Cargando…

Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma

SIMPLE SUMMARY: Despite significant advancements in neuroblastoma therapy, over half of the children with high-risk neuroblastoma will suffer disease relapse. Protein phosphatase 2A (PP2A) is a tumor suppressor that is decreased in neuroblastoma. Previous studies with FTY720, an immunomodulatory age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bownes, Laura V., Marayati, Raoud, Quinn, Colin H., Beierle, Andee M., Hutchins, Sara C., Julson, Janet R., Erwin, Michael H., Stewart, Jerry E., Mroczek-Musulman, Elizabeth, Ohlmeyer, Michael, Aye, Jamie M., Yoon, Karina J., Beierle, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026148/ https://www.ncbi.nlm.nih.gov/pubmed/35454859 http://dx.doi.org/10.3390/cancers14081952

Ejemplares similares

Downregulation of PDGFRß Signaling Overcomes Crizotinib Resistance in a TYRO3 and ALK Mutated Neuroendocrine-Like Tumor
por: Quinn, Colin H., et al.
Publicado: (2021)

EZH2 inhibition decreases neuroblastoma proliferation and in vivo tumor growth
por: Bownes, Laura V., et al.
Publicado: (2021)

Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022)

Using 3D-bioprinted models to study pediatric neural crest-derived tumors
por: Quinn, Colin H, et al.
Publicado: (2023)

Rapid Characterization of Solid Tumors Using Resonant Sensors
por: Beierle, Andee M., et al.
Publicado: (2022)

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells
por: Stafman, Laura L., et al.
Publicado: (2019)

9-cis-UAB30, a novel rexinoid agonist, decreases tumorigenicity and cancer cell stemness of human neuroblastoma patient-derived xenografts
por: Marayati, Raoud, et al.
Publicado: (2020)

Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines
por: Bownes, Laura V, et al.
Publicado: (2021)

The Role of PIM Kinases in Pediatric Solid Tumors
por: Julson, Janet Rae, et al.
Publicado: (2022)

Adrenal extramedullary hematopoiesis in the setting of anti-Diego antibody and congenital dyserythropoietic anemia
por: Julson, Janet Rae, et al.
Publicado: (2022)

Artificial Tumor Microenvironments in Neuroblastoma
por: Quinn, Colin H., et al.
Publicado: (2021)

CRISPR/Cas9-mediated knockout of PIM3 suppresses tumorigenesis and cancer cell stemness in human hepatoblastoma cells
por: Marayati, Raoud, et al.
Publicado: (2022)

Immunotherapy in Pediatric Solid Tumors—A Systematic Review
por: Marayati, Raoud, et al.
Publicado: (2019)

UAB30, A Novel Rexinoid Agonist, Decreases Stemness In Group 3 Medulloblastoma Human Cell Line Xenografts
por: Williams, Adele P., et al.
Publicado: (2019)

PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma
por: Marayati, Raoud, et al.
Publicado: (2021)

Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
por: Stafman, Laura L., et al.
Publicado: (2019)

The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor
por: Aye, Jamie M., et al.
Publicado: (2019)

Targeting PIM kinase as a therapeutic strategy in human hepatoblastoma
por: Stafman, Laura L., et al.
Publicado: (2018)

Invasive pulmonary aspergillosis presenting with tracheopleural fistula in a pediatric patient with a history of rhabdomyosarcoma
por: Khatun, Munteha, et al.
Publicado: (2023)

FTY720 Decreases Tumorigenesis in Group 3 Medulloblastoma Patient-Derived Xenografts
por: Garner, Evan F., et al.
Publicado: (2018)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Neuroblastoma
por: Gillory, Lauren A., et al.
Publicado: (2013)

Targeting Focal Adhesion Kinase Suppresses the Malignant Phenotype in Rhabdomyosarcoma Cells()
por: Waters, Alicia M., et al.
Publicado: (2016)

Cell Proliferation in Neuroblastoma
por: Stafman, Laura L., et al.
Publicado: (2016)

Investigation of PP2A and Its Endogenous Inhibitors in Neuroblastoma Cell Survival and Tumor Growth
por: Williams, Adele P., et al.
Publicado: (2018)

Pleuropulmonary blastoma in an adolescent
por: Bownes, Laura V., et al.
Publicado: (2020)

Cancer Stem Cells and Their Interaction with the Tumor Microenvironment in Neuroblastoma
por: Garner, Evan F., et al.
Publicado: (2015)

A pediatric case of xanthogranulomatous pyelonephritis in the setting of Covid-19 and multi-system inflammatory syndrome (MIS-C)
por: Julson, Janet R., et al.
Publicado: (2022)

Preclinical Evaluation of Engineered Oncolytic Herpes Simplex Virus for the Treatment of Pediatric Solid Tumors
por: Megison, Michael L., et al.
Publicado: (2014)

Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma()()
por: Stafman, Laura L., et al.
Publicado: (2018)

Protein phosphatase 2A as a therapeutic target in inflammation and neurodegeneration
por: Clark, Andrew R., et al.
Publicado: (2019)

Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors
por: Miller, Aubrey L., et al.
Publicado: (2017)

Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
por: Anderson, Marybeth, et al.
Publicado: (2016)

Sentiments about Mental Health on Twitter—Before and during the COVID-19 Pandemic
por: Beierle, Felix, et al.
Publicado: (2023)

Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016)

Targeting Pediatric Cancer Stem Cells with Oncolytic Virotherapy
por: Friedman, Gregory K., et al.
Publicado: (2012)

Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
por: Yu, Howard, et al.
Publicado: (2023)

Dual-Specificity Phosphatases in Neuroblastoma Cell Growth and Differentiation
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2019)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma()
por: Waters, Alicia M., et al.
Publicado: (2016)

Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
por: Lipner, Matthew B., et al.
Publicado: (2016)

WIP1 Phosphatase as a Potential Therapeutic Target in Neuroblastoma
por: Richter, Mark, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_cvpal6a7o016mesiubg1ndopc6